Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02073084 · ClinicalTrials.gov registry record · Phase 1
A Thorough Corrected QT Interval Trial
A Phase 1 study, sponsored by Kowa Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 56
- Enrollment target
NCT02073084 is a Phase 1 study that has completed, run by Kowa Research Institute. The registered enrollment target is 56 participants.
The verdict
NCT02073084, a Phase 1 study, has completed, sponsored by Kowa Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of K-877 on ECG parameters with a focus on cardiac repolarization compared with placebo in healthy adult subjects.
Interventions
- OTHER Placebo
- DRUG Moxifloxacin
- DRUG K-877 Low Dose
- DRUG K-877 High Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2014-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02073084
The ClinicalTrials.gov registry entry for NCT02073084 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kowa Research Institute, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02073084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02073084 about?
NCT02073084 is a clinical study titled "A Thorough Corrected QT Interval Trial". The purpose of this study is to determine the effects of K-877 on ECG parameters with a focus on cardiac repolarization compared with placebo in healthy adult subjects.
What is the current status of trial NCT02073084?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 56 participants. The study started on 2014-01.
What interventions are being tested in trial NCT02073084?
The interventions under investigation include: Placebo (OTHER), Moxifloxacin (DRUG), K-877 Low Dose (DRUG), K-877 High Dose (DRUG).
Who is sponsoring clinical trial NCT02073084?
This trial is sponsored by Kowa Research Institute, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.